Regarding Wegovy and kidney stones , there is currently no established direct causal link between semaglutide use and kidney stone formation based on clinical trial data and post-marketing surveillance as reported in the Wegovy Summary of Product Characteristics (SmPC)
You do not need to declare them separately, but keeping them together with your medication in a clear, organized case prevents confusion
Daarvoor kunnen aanvullende elementanalyses nodig zijn, zoals ICP-MS of ICP-OES
[Over-expression of glutathione S-transferase in Streptomyces]
A 2006 Achilles-detachment study by Krivic and colleagues in the same journal applied BPC-157 intraperitoneally once daily at 10 g/kg, 10 ng/kg, or 10 pg/kg for 30 days in rats and reported that tendon-to-bone tissue, which did not heal spontaneously in saline controls, recovered with BPC-157 treatment, with directionally improved load-to-failure, stiffness, Young's modulus, and collagen organization at days 121, including in animals where healing had been impaired by 1 mg/kg 6-methylprednisolone though the abstract does not report numeric effect sizes or p-values
